Eli Lilly's first weight-loss pill could expand access to GLP-1s around the globe, executive says
Business
In This Story LLY -4.21% SIVB NVO -9.81% MS -8.04% Eli Lilly ( LLY -4.21% ) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide. Suggested Reading Blame Trump's tariffs for the stock market carnage, strategists say Amazon keeps finding ways to give Donald Trump money Mark Zuckerberg wore a $300,000 Rolex to a UFC match Donald Trump will 'burn' Elon Musk soon, Anthony Scaramucci predicts CC Share Subtitles Off English Share this Video Facebook Twitter
din zilele anterioare